title: [The initiation of G2/M checkpoint by diallyl disulfide requires the activation of p38 MAP kinase in HL-60 cells].
abstract: OBJECTIVE
  To explore the molecular mechanisms of G(2)/M checkpoint initiated by diallyl disulfide (DADS) in HL-60 cells.
  
  
  METHODS
  Cell viability was determined by MTT assay. Cell cycle was assayed by flow cytometry. The expression of phospho-p38, Cdc25B and Cdc2, and p38 mRNA were measured by Western blotting and RT-PCR, respectively.
  
  
  RESULTS
  After treatment with DADS at 5 - 160 micro mol/L for 0 - 72 h, the growth of HL-60 cells were suppressed in a concentration-dependent manner and the inhibitory effect of DADS (20 micro mol/L) was similar to that of ATRA (10 nmol/L) (P > 0.05). Incubation of HL-60 cells with DADS (20 micro mol/L) for 12 h could activate G(2)/M checkpoint and increase the expression of phospho-p38 MAPK, followed by the expression of phospho-Cdc25B and phospho-Cdc2 (P < 0.05). SB202190, a specific inhibitor of p38 MAPK, markedly blocked the phosphorylation of p38 MAPK, Cdc25B and Cdc2 (P < 0.05).
  
  
  CONCLUSIONS
  DADS could induce the G(2)/M arrest in HL-60 cells which may be involved in the activation of p38 MAP kinase.
authors.affiliation: Institute of Pharmacy and Pharmacology, Medical School, Nanhua University, Hengyang of Hunan Province 421001, China.
authors.forename: Li-ming
authors.initials: LM
authors.lastname: Tan
authors.forename: Meng-xia
authors.initials: MX
authors.lastname: Zhang
authors.forename: Hong-mei
authors.initials: HM
authors.lastname: Luo
authors.forename: Yong-zhi
authors.initials: YZ
authors.lastname: Zeng
authors.forename: Jian-min
authors.initials: JM
authors.lastname: Li
authors.forename: Ze-wen
authors.initials: ZW
authors.lastname: Cui
authors.forename: Xiao-hong
authors.initials: XH
authors.lastname: Zhang
authors.forename: Sheng-song
authors.initials: SS
authors.lastname: Tang
mesh_terms: D000498:Allyl Compounds / Q000494:pharmacology*; D015153:Blotting, Western; D016203:CDC2 Protein Kinase / Q000235:genetics / Q000378:metabolism; D002455:Cell Division / Q000187:drug effects*; D049109:Cell Proliferation / Q000187:drug effects; D002470:Cell Survival / Q000187:drug effects; D004220:Disulfides / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D004789:Enzyme Activation / Q000187:drug effects; D005434:Flow Cytometry; D016195:G2 Phase / Q000187:drug effects*; D015870:Gene Expression / Q000187:drug effects; D018922:HL-60 Cells; D006801:Humans; D010766:Phosphorylation / Q000187:drug effects; D020133:Reverse Transcriptase Polymerase Chain Reaction; D020687:cdc25 Phosphatases / Q000235:genetics / Q000378:metabolism; D048051:p38 Mitogen-Activated Protein Kinases / Q000235:genetics / Q000378:metabolism*
chemical_list: D000498:Allyl Compounds; D004220:Disulfides; C028009:diallyl disulfide; D016203:CDC2 Protein Kinase; D048051:p38 Mitogen-Activated Protein Kinases; C517008:CDC25B protein, human; D020687:cdc25 Phosphatases